A large international study has found limits in existing diagnostic methods that judge obesity using body mass index (BMI) alone. The analysis said health risks linked to obesity can be classified more accurately by also measuring waist circumference and waist-to-height ratio and evaluating organ function.
Medical News Today reported on Nov. 14 that an international research team including King's College London published the findings in the journal Nature after analysing health data from 844,108 adults in China, Britain, the United States and Spain.
The researchers compared traditional BMI-based obesity diagnosis with a new diagnostic framework proposed by an international medical expert committee in 2025.
It found that judging obesity by BMI alone missed excess body fat in 5.2 to 8.6 percent of those studied, while 1.2 to 3.1 percent were wrongly classified as obese.
The new diagnostic framework has two stages. It first adds measures such as waist circumference and waist-to-height ratio to BMI to check for excess body fat. It then classifies cases as "clinical obesity" or "pre-clinical obesity" depending on whether body fat affects organ function or daily life.
Clinical obesity refers to a state in which excess body fat causes actual impairment in organ function, including the heart and respiratory system, or in physical activity. Pre-clinical obesity refers to a state in which body fat is excessive but no clear functional damage has yet been confirmed.
The analysis found clinical obesity accounted for about 23 to 31 percent of all obesity cases, and prevalence in the overall population was 5.6 to 10.9 percent.
Differences were also found in mortality risk. The all-cause mortality risk ratio for the clinical obesity group was 1.69, higher than 1.19 for the pre-clinical obesity group.
However, 77 to 91 percent of those classified as pre-clinical obesity did not progress to clinical obesity over 10 years. This means not all pre-clinical obesity leads to disease in the short term.
Study lead Francesco Rubino (프란체스코 루비노) said, "What matters is how excess fat affects organ function, rather than weight."
The researchers said they expect the new diagnostic framework to reduce unnecessary treatment and help identify patients who need treatment early. They added that pre-clinical obesity is not a state without health risks and that preventive treatment or continued monitoring may be needed depending on individual risk.